Abstract:Macroautophagy/autophagy is an evolutionarily conserved process that involves the selective degradation of cytoplasmic components within lysosomes in response to starvation. Autophagy is an ancient defense mechanism that has been closely integrated with the immune system and has multiple effects on innate and adaptive immunity. The pro-inflammatory and anti-inflammatory cytokines can activate and inhibit autophagy, respectively. TNFAIP8L2/TIPE2 (tumor necrosis factor, alpha-induced protein 8-like 2) is a newly identified immune negative regulator of innate and adaptive immunity that plays an important role in immune homeostasis. However, whether and how TNFAIP8L2 controls autophagy is still unknown. Murine TNFAIP8L2 can directly bind to and block the RAC1 GTPase activity to regulate innate immunity. RAC1 can also bind to MTOR and regulate MTORC1 cellular localization and activity. Here, we find that TNFAIP8L2 can compete with MTOR for binding to the GTP-bound state of RAC1 and negatively regulate MTORC1 activity. Interestingly, TNFAIP8L2 overexpression fails to induce autophagy flux by the suppression of the MTOR activity under glutamine and serum starvation. Instead, TNFAIP8L2 appears to impair autophagic lysosome reformation (ALR) during prolonged starvation. Finally, we demonstrate that TNFAIP8L2 overexpression leads to a defect in MTOR reactivation and disrupts autophagy flux, thereby leading to cell death. Furthermore, TNFAIP8L2 deficiency can exacerbate the inflammatory response and lung injury by controlling the MTOR activity in an LPS-induced mouse endotoxemia model. Our study reveals a novel role of TNFAIP8L2 in autophagy by regulating the RAC1-MTORC1 axis that supports its potential as a target for therapeutic treatment.Abbreviations: ALR: autophagic lysosome reformation; BafA1: bafilomycin A1; BMDMs: bone marrow-derived macrophages; Co-IP: Co-Immunoprecipitation; LAMP1: lysosomal associated membrane protein 1; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MTORC1: mechanistic target of rapamycin kinase complex 1; RAPA: rapamycin; RPS6: ribosomal protein S6; SQSTM1/p62: sequestosome 1; Starv: Starvation; TNFAIP8L2/TIPE2: tumor necrosis factor-alpha-induced protein-8 like-2.

mTOR interacts with AIF to positively regulate autophagy

Mtorc1, the Master Regulator of Autophagy

Mtorc1 Phosphorylates Acetyltransferase P300 to Regulate Autophagy and Lipogenesis.

Mtorc1-Regulated and HUWE1-Mediated WIPI2 Degradation Controls Autophagy Flux

AMPK Regulates Autophagy by Phosphorylating BECN1 at Threonine 388.

XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling.

The Transcription Factor P8 Regulates Autophagy in Response to Palmitic Acid Stress Via a Mammalian Target of Rapamycin (Mtor)-Independent Signaling Pathway

mTORC2: a multifaceted regulator of autophagy

mTORC2: The other mTOR in autophagy regulation

DAP1, a novel substrate of mTOR, negatively regulates autophagy

Atg1-mediated Atg11 Phosphorylation is Required for Selective Autophagy by Regulating Its Association with Receptor Proteins.

Regulation of PIK3C3/VPS34 Complexes by MTOR in Nutrient Stress-Induced Autophagy

TNFAIP8L2/TIPE2 Impairs Autolysosome Reformation Via Modulating the RAC1-MTORC1 Axis.

Unexpected roles for AMPK in the suppression of autophagy and the reactivation of MTORC1 signaling during prolonged amino acid deprivation

Ampk And Mtor In Nutrient Signaling And Autophagy Regulation

Molecular regulation of autophagy machinery by mTOR‐dependent and ‐independent pathways

Autophagy gets a brake: DAP1, a novel mTOR substrate, is activated to suppress the autophagic process

Termination of Autophagy and Reformation of Lysosomes Regulated by Mtor

The TORC1 activates Rpd3L complex to deacetylate Ino80 and H2A.Z and repress autophagy

MTORC1 Regulates Autophagic Membrane Growth by Targeting WIPI2